BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32262877)

  • 1. Efficient delivery of small interfering RNA into cancer cells using dodecylated dendrimers.
    Chang H; Zhang Y; Li L; Cheng Y
    J Mater Chem B; 2015 Nov; 3(41):8197-8202. PubMed ID: 32262877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of PAMAM dendrimers for cellular delivery of siRNA.
    Waite CL; Sparks SM; Uhrich KE; Roth CM
    BMC Biotechnol; 2009 Apr; 9():38. PubMed ID: 19389227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
    Golkar N; Samani SM; Tamaddon AM
    Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery.
    Wang M; Cheng Y
    Acta Biomater; 2016 Dec; 46():204-210. PubMed ID: 27662807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
    Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
    Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAMAM Dendrimers as a Delivery System for Small Interfering RNA.
    Kheiriabad S; Ghaffari M; Dolatabadi JEN; Hamblin MR
    Methods Mol Biol; 2020; 2115():91-106. PubMed ID: 32006396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost.
    Liu H; Wang H; Yang W; Cheng Y
    J Am Chem Soc; 2012 Oct; 134(42):17680-7. PubMed ID: 23050493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimers as carriers for siRNA delivery and gene silencing: a review.
    Wu J; Huang W; He Z
    ScientificWorldJournal; 2013; 2013():630654. PubMed ID: 24288498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
    Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
    Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-engineered dendrimers with a diaminododecane core achieve efficient gene transfection and low cytotoxicity.
    Chang H; Wang H; Shao N; Wang M; Wang X; Cheng Y
    Bioconjug Chem; 2014 Feb; 25(2):342-50. PubMed ID: 24410081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
    Xu L; Yeudall WA; Yang H
    Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer Nanovectors for SiRNA Delivery.
    Liu X; Peng L
    Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkyl sulfonyl derivatized PAMAM-G2 dendrimers as nonviral gene delivery vectors with improved transfection efficiencies.
    Morales-Sanfrutos J; Megia-Fernandez A; Hernandez-Mateo F; Giron-Gonzalez MD; Salto-Gonzalez R; Santoyo-Gonzalez F
    Org Biomol Chem; 2011 Feb; 9(3):851-64. PubMed ID: 21120228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleobase-modified dendrimers as nonviral vectors for efficient and low cytotoxic gene delivery.
    Wang H; Wei H; Huang Q; Liu H; Hu J; Cheng Y; Xiao J
    Colloids Surf B Biointerfaces; 2015 Dec; 136():1148-55. PubMed ID: 26613860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
    Thuy le T; Mallick S; Choi JS
    Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy.
    Abedi Gaballu F; Cho WC; Dehghan G; Zarebkohan A; Baradaran B; Mansoori B; Abbaspour-Ravasjani S; Mohammadi A; Sheibani N; Aghanejad A; Ezzati Nazhad Dolatabadi J
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of surface modification on the cytotoxicity of PAMAM dendrimers.
    Jevprasesphant R; Penny J; Jalal R; Attwood D; McKeown NB; D'Emanuele A
    Int J Pharm; 2003 Feb; 252(1-2):263-6. PubMed ID: 12550802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectively Fluorinated PAMAM-Arginine Conjugates as Gene Delivery Vectors.
    Romani C; Gagni P; Sponchioni M; Volonterio A
    Bioconjug Chem; 2023 Jun; 34(6):1084-1095. PubMed ID: 37221455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.